A progress in neuroimaging research on the central mechanisms of botulinum toxin in the treatment of focal dystonia

Journal Title: Chinese Journal of Nervous and Mental Diseases - Year 2024, Vol 50, Issue 7

Abstract

Botulinum toxin (BoNT) is currently the first-line method for treating focal dystonia, which causes muscle paralysis by chemical denervation. Recent neuroimaging studies have found that BoNT treatment could alter neuroplasticity in the brain of patients with focal dystonia. However, the specific central nervous system mechanisms have not been fully elucidated. To this end, here we review the neuroimaging studies on BoNT treatment for dystonia from three aspects: functional magnetic resonance imaging, structural magnetic resonance imaging, and positron emission tomography imaging. It suggests that BoNT may improve the symptoms of dystonia patients by affecting functional connectivity, microstructure, and metabolic levels of the cortex, basal ganglia, thalamus, and cerebellum, etc. Therefore, this review will provide a theoretical reference for further exploring the mechanism and developing potential therapeutic targets of dystonia.

Authors and Affiliations

Qinying MU, Junhao HU, Fuhao MA, Hao WANG, Weikang DOU, Liyi CHI, Ming. SHI

Keywords

Related Articles

Progress in the study of insomnia and its non-drug treatment in relation to heart rate variability

Heart rate variability (HRV) is an important indicator of autonomic nervous system function, reflecting the dynamic balance of autonomic regulation. Reviewing the effects of insomnia on HRV and the potential effects of n...

Expert consensus on the rational use of psychotropic drugs related to intensive care medicine

Critical care medicine-related treatment is an interdisciplinary and multi-professional process, often leading to secondary or concomitant mental disorders in clinical practice. Currently, there is no consensus on the ph...

Comparison of abnormal cortical inhibition in schizophrenia and major depression disorder

[Objective] To compare cortical inhibition (CI) function between patients with schizophrenia and depression, and to explore the correlation between CI function and clinical symptoms. [Methods] A total of 35 first episode...

Gender differences in the impact of modified electroconvulsive therapy on cognitive function in middle-aged and young patients with depression

ObjectivePreliminary exploration of the effects of modified electroconvulsive therapy (MECT) on cognitive function and gender differences in middle-aged and young patients with depressive episodes.MethodsA group of middl...

An intervention study of Orff-music therapy for long-term hospitalized patients with schizophrenia

[Objective] This research aims to investigate the impact of Orff music therapy on long-term schizophrenic patients in hospitals. [Methods] The study was a randomized, single-blind controlled trial conducted from April,20...

Download PDF file
  • EP ID EP750521
  • DOI 10.3969/j.issn.1002-0152.2024.07.008
  • Views 1
  • Downloads 0

How To Cite

Qinying MU, Junhao HU, Fuhao MA, Hao WANG, Weikang DOU, Liyi CHI, Ming. SHI (2024). A progress in neuroimaging research on the central mechanisms of botulinum toxin in the treatment of focal dystonia. Chinese Journal of Nervous and Mental Diseases, 50(7), -. https://europub.co.uk/articles/-A-750521